Neurodegeneration: A "Vicious Cycle" Involving Mitochondria, Glia, and Neuronal Death

Efforts to reduce the personal and societal burden of neurodegenerative disease (ND) hinge on the identification of the underlying molecular mechanism(s) that causes neuronal death. One common aspect of neuronal death in Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), and Huntington’s disease (HD) is the relationship to the buildup of neurotoxic proteins. Glial cells, normally neuroprotective, can be transformed into a neuroinflammatory state (“A1” for astrocytes) stimulated by this neuronal detritus and by microglial activation. Interestingly, pathological mitochondrial fission mediated by Drp1-Fis1 interaction (as opposed to physiological fission through Drp1-Mff) is also a characteristic of many ND. In their new study, Joshi et al. used various mouse ND models to reveal a process where microglia expressing neurotoxic proteins released dysfunctional and fragmented mitochondria that drove A1 astrocyte-triggered neuroinflammation and subsequent innate immune-mediated neuronal death, with the resultant debris contributing to additional inflammation. Importantly, disruption of the Drp1-Fis1 interaction ameliorated these effects. The authors stressed that the fate of neurons was determined by the extracellular ratio of damaged to normal mitochondria, which was dependent on the amount of pathological fission in microglia. Together, the results suggest that inhibition of Drp1-Fis1-mediated mitochondrial fission, with the goal of increasing the ratio between functional and damaged mitochondria, may offer a new approach to neuroprotection in various NDs.

GeneTex is proud to offer an extensive selection of antibodies for neurodegenerative disease and mitochondria research. Please see the featured products below relevant to the study described above.

Featured Products

FIS1 antibody (GTX111010)	Iba1 antibody (GTX100042)	GFAP antibody (GTX108711)	TNF alpha antibody (GTX110520)
SOD1 (mutant) antibody [MS785] (GTX57211)	beta Amyloid (1-42) antibody – Conformation Specific (GTX134510)	COX4 antibody (GTX114330)	TOMM20 antibody (GTX133756)

Category Cat. No. Product Name Reactivity Applications Validation Microglia GTX100042 Iba1 antibody Hu, Ms, Rat WB, ICC/IF, IHC-P, IHC-Fr, FACS, IHC   GTX134087 TMEM119 antibody Ms IHC-P, IHC-Fr   Astrocytes GTX108711 GFAP antibody Hu, Ms, Rat WB, ICC/IF, IHC-P, IHC-Fr, IHC   GTX109121 Glutamine synthetase antibody Hu, Ms, Rat WB, ICC/IF, IHC-P, IHC-Fr, IP    GTX129573 S100 beta antibody Hu, Ms, Rat, Squirrel WB, ICC/IF, IHC-P, IHC-Fr   GTX133151 Aquaporin 4 antibody Ms, Rat WB, ICC/IF, IHC-P, IHC-Fr Inflammation cytokines GTX110520 TNF alpha antibody Hu, Ms, Rat WB, ICC/IF, IHC-P    GTX110527 IL6 antibody Hu, Ms WB, IHC-P, IHC-Fr     GTX74034 IL1 beta antibody Hu, Ms, Rat WB, ICC/IF, IHC-P, IHC-Fr, ELISA, Functional Assay, IHC   Neurodegeneration GTX134510 beta Amyloid (1-42) antibody – Conformation Specific Hu, Ms IHC-P, Dot, ELISA GTX57211 SOD1 (mutant) antibody [MS785] Hu WB, ICC/IF, IP, ELISA, IHC Mitochondria GTX111010 FIS1 antibody Hu, Ms, Rat WB, ICC/IF, IHC-P   GTX114330 COX4 antibody Hu, Ms, Rat WB, ICC/IF, IHC-P, IHC-Fr   GTX133756 TOMM20 antibody Hu, Ms, Rat WB, IHC-P

Reference

1. Joshi et al. Nat Neurosci. 2019 Oct;22(10):1635-1648.